Videos
Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).
Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.
Advertisement
Advertisement
Trending on CURE
1
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
2
ROSELLA Trial Extends Survival in Platinum-Resistant Ovarian Cancer
3
FDA Grants Orphan Drug Designation to Zenocutuzumab for Cholangiocarcinoma
4
Immunotherapy Combo Shows Potential Progress in Some Pancreatic Cancers
5